These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 9331090

  • 1. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
    O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJ, Kohn KW.
    Cancer Res; 1997 Oct 01; 57(19):4285-300. PubMed ID: 9331090
    [Abstract] [Full Text] [Related]

  • 2. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
    Bae I, Fan S, Bhatia K, Kohn KW, Fornace AJ, O'Connor PM.
    Cancer Res; 1995 Jun 01; 55(11):2387-93. PubMed ID: 7757991
    [Abstract] [Full Text] [Related]

  • 3. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
    Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, O'Connor PM, Fornace AJ.
    Cancer Res; 1996 Feb 15; 56(4):840-7. PubMed ID: 8631022
    [Abstract] [Full Text] [Related]

  • 4. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.
    Takimoto R, Wang W, Dicker DT, Rastinejad F, Lyssikatos J, el-Deiry WS.
    Cancer Biol Ther; 2002 Feb 15; 1(1):47-55. PubMed ID: 12174820
    [Abstract] [Full Text] [Related]

  • 5. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
    Morgan SE, Kim R, Wang PC, Bhat UG, Kusumoto H, Lu T, Beck WT.
    Oncogene; 2000 Oct 12; 19(43):5010-9. PubMed ID: 11042688
    [Abstract] [Full Text] [Related]

  • 6. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996 Oct 12; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 7. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B, Pennell N, Berinstein NL.
    Oncogene; 1998 Nov 05; 17(18):2339-50. PubMed ID: 9811465
    [Abstract] [Full Text] [Related]

  • 8. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
    Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM.
    Int J Radiat Biol; 1999 Mar 05; 75(3):301-16. PubMed ID: 10203181
    [Abstract] [Full Text] [Related]

  • 9. Specific induction of gadd45 in human melanocytes and melanoma cells after UVB irradiation.
    Pedeux R, Lefort K, Cuenin C, Cortes U, Kellner K, Doré JF, Nakazawa H.
    Int J Cancer; 2002 Apr 20; 98(6):811-6. PubMed ID: 11948456
    [Abstract] [Full Text] [Related]

  • 10. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
    Landers JE, Cassel SL, George DL.
    Cancer Res; 1997 Aug 15; 57(16):3562-8. PubMed ID: 9270029
    [Abstract] [Full Text] [Related]

  • 11. Growth factor modulation of p53-mediated growth arrest versus apoptosis.
    Canman CE, Gilmer TM, Coutts SB, Kastan MB.
    Genes Dev; 1995 Mar 01; 9(5):600-11. PubMed ID: 7698649
    [Abstract] [Full Text] [Related]

  • 12. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
    Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C.
    Int J Cancer; 2002 Feb 01; 97(4):439-45. PubMed ID: 11802204
    [Abstract] [Full Text] [Related]

  • 13. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].
    Jiang M, Shao Z, Wu J.
    Zhonghua Zhong Liu Za Zhi; 1998 May 01; 20(3):181-4. PubMed ID: 10921001
    [Abstract] [Full Text] [Related]

  • 14. Expression of cell cycle regulator genes in KB, a human squamous cell carcinoma cell line, after irradiation.
    Uno M, Otsuki T, Hiratsuka J, Yoden E, Aihara T, Harada T, Imajo Y.
    Int J Oncol; 2000 Nov 01; 17(5):947-54. PubMed ID: 11029497
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the GADD45 response to ionizing radiation in WI-L2-NS cells, a p53 mutant cell line.
    Carrier F, Bae I, Smith ML, Ayers DM, Fornace AJ.
    Mutat Res; 1996 Jun 10; 352(1-2):79-86. PubMed ID: 8676920
    [Abstract] [Full Text] [Related]

  • 16. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.
    Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B, Barnett GH.
    Oncogene; 1996 Sep 19; 13(6):1279-85. PubMed ID: 8808702
    [Abstract] [Full Text] [Related]

  • 17. Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.
    Gudas JM, Nguyen H, Li T, Sadzewicz L, Robey R, Wosikowski K, Cowan KH.
    Carcinogenesis; 1996 Jul 19; 17(7):1417-27. PubMed ID: 8706243
    [Abstract] [Full Text] [Related]

  • 18. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
    DeHaan RD, Yazlovitskaya EM, Persons DL.
    Cancer Chemother Pharmacol; 2001 Nov 19; 48(5):383-8. PubMed ID: 11761456
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction.
    Neuteboom ST, Karjian PL, Boyer CR, Beryt M, Pegram M, Wahl GM, Shepard HM.
    Mol Cancer Ther; 2002 Apr 19; 1(6):377-84. PubMed ID: 12477050
    [Abstract] [Full Text] [Related]

  • 20. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV, Rauth S, Das Gupta TK, Gudkov AV.
    Oncogene; 2003 Jul 31; 22(31):4911-7. PubMed ID: 12894234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.